A Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell Malignancies
A Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell Malignancies
Recruiting · NCT06045910 · Registry updated 2025-07-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell Malignancies | B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, diffuse large B-cell lymphoma, follicular lymphoma, immune system disorder, immunoproliferative disorder, large B-cell lymphoma, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mantle cell lymphoma, neoplasm | Recruiting | Phase 1 / Phase 2 | 2025-07-28 | NCT06045910 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Aleta BioTherapeutics | 1 |
| Cancer Research UK | 59 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cambridge University Hospitals | Cambridge | United Kingdom | 4 |
| Manchester Royal Infirmary | Manchester | United Kingdom | 10 |
| Royal Marsden Hospital | Sutton | United Kingdom | 11 |
| St James's University Hospital | Leeds | United Kingdom | 16 |
| The Christie Hospital | Manchester | United Kingdom | 13 |
| University Hospital Birmingham NHS foundation Trust | Birmingham | United Kingdom | 2 |
| University Hospital London Hospital | London | United Kingdom | 1 |